[HTML][HTML] Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
IF Blixter - Journal of Thrombosis and Haemostasis, 2014 - Elsevier
Introduction Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
A Hillarp, KM Gustafsson, L Faxälv… - Journal of Thrombosis …, 2014 - jthjournal.org
Introduction Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
A Hillarp, KM Gustafsson, L Faxälv… - … of Thrombosis and …, 2014 - portal.research.lu.se
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa
assays. — Lund University Skip to main navigation Skip to search Skip to main content Lund …
assays. — Lund University Skip to main navigation Skip to search Skip to main content Lund …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
A Hillarp, KM Gustafsson, L Faxälv… - … of thrombosis and …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
A Hillarp, KM Gustafsson, L Faxälv… - Journal of Thrombosis …, 2014 - lup.lub.lu.se
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa
assays. | Lund University Publications Skip to main content LUND UNIVERSITY | LUND …
assays. | Lund University Publications Skip to main content LUND UNIVERSITY | LUND …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
A Hillarp, K Gustafsson, L Faxälv… - Journal of Thrombosis …, 2014 - diva-portal.org
OBJECTIVES: To investigate the effects of apixaban on commonly used coagulation
methods, and to evaluate anti-FXa assays for specific determination of the drug …
methods, and to evaluate anti-FXa assays for specific determination of the drug …
[引用][C] Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
A Hillarp, KM Gustafsson, L Faxälv… - Journal of Thrombosis …, 2014 - cir.nii.ac.jp
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa
assays | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
assays | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays.
A Hillarp, KM Gustafsson, L Faxälv… - … of Thrombosis and …, 2014 - europepmc.org
Objectives To investigate the effects of apixaban on commonly used coagulation methods,
and to evaluate anti-FXa assays for specific determination of the drug concentration …
and to evaluate anti-FXa assays for specific determination of the drug concentration …
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
A Hillarp, KM Gustafsson, L Faxälv… - … of Thrombosis and …, 2014 - Wiley Online Library
Introduction Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …
treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the …